Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Sell
29,469
-34,173
-54% -$48.1K 0.01% 910
2026
Q1
$94.8K Buy
63,642
+20,015
+46% +$30.4K 0.02% 694
2025
Q4
$57.6K Buy
+43,627
New +$54.7K 0.01% 649

Other funds holding GERN

Abel Hall LLC's GERN Position: Q2 2026 in Review

Abel Hall LLC reduced its Geron (GERN) stake by 54% in Q2 2026, selling an estimated $48.1K and leaving 29,469 shares worth $37.7K. The position accounts for 0.01% of the portfolio, ranked #910.

Abel Hall LLC first reported a position in GERN in Q4 2025 and has held it in 3 quarters since. The position peaked at $94.8K in Q1 2026. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Abel Hall LLC held 29,469 shares of Geron worth $37.7K as of Q2 2026.
  • Abel Hall LLC sold 34,173 Geron shares in Q2 2026, an estimated $48.1K.
  • Geron made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #910 holding.
  • Abel Hall LLC first reported a position in Geron in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Geron position peaked at $94.8K in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.